FDA APPROVED? Look At How Many FDA Approved Drugs Had To Later Be REMOVED

Why should you care if anything is FDA approved?

According to the data, this government agency and its partner in crime The CDC have been wrong more than a handful of times, and are dubious at best when it comes to issues of funding…..

Here is a list of drugs which were previously FDA approved, but later had to be withdrawn from the market either because they were ineffective, or due to safety concerns.

Given The FDA’s lack of a great track record, and given palpable concerns over funding for both agencies—many are left feeling concerned, and rightly so.

Government cannot push these mandates; especially with such little data…..

Some drugs which bore the stamp of FDA approval stayed on the market for decades before better research and data cited them over safety and effectiveness.

Think about that for a second……it takes years of research sometimes to uncover these problems, and they went ahead and approved these vaccines in a matter of months.

Here’s more on both The FDA and The CDC:

The FDA regularly has to pull drugs from the market, which it previously approved because the drugs are later found to be "unsafe" or ineffective.https://t.co/ralG1H0HoC#FDAapproved #CDC #VaccineMandates pic.twitter.com/nV6h96Cd4G

— Vince Quill (@VinceQuill) September 2, 2021

Information funded by the U.S. Government and Billionaires. The same U.S. government who been manufacturing support for their atrocities since it’s inception. https://t.co/IeHf1XYkf9 pic.twitter.com/Ng6iVCdGf2

— The Sheep Hate This Account😌 (@skye_daddy) September 2, 2021

The Project on Government Oversight had this to say about The FDA, and a full copy of their findings can be found here:

The Food and Drug Administration’s (FDA) questionable oversight of a blockbuster blood thinner raises serious concerns about whether the agency is failing in its role to keep consumers safe, according to a report published today by the Project On Government Oversight.

POGO’s report describes a long series of questionable calls the FDA has made in its oversight of Pradaxa, a new-generation blood thinner that has been named in thousands of “adverse event” reports, including cases involving patient deaths. Some of the most alarming issues include the FDA’s handling of the clinical trial used to win Pradaxa’s approval.

POGO found that dozens of doctors the FDA had cited for violating standards in prior clinical trials, including repeat and even three-time offenders, were allowed to enroll and monitor patients in the Pradaxa trial. That was par for the course; the agency has taken a toothless approach to doctors who violate standards of clinical trials, disqualifying only 26 out of thousands in the realm of drug evaluation over a 10-year period, POGO found.

 

FDA updates list of drug products withdrawn or removed from the market. https://t.co/qqNx3zgcuw by @FedRegister pic.twitter.com/nVqie468gg

— HID (@thePAexperts) October 18, 2016

Note that these two senior level vaccine officials are stepping down from The FDA. https://t.co/NEKVe85dEr#FDA #FDAapproved #Vaccine

— Vince Quill (@VinceQuill) September 2, 2021

https://twitter.com/LV_BTC/status/1433199525649260546?t=uF-MsZ-0-Va6DymgDft49Q&s=19

Two senior Vaccine officials recently resigned from The FDA according to The New York Post:

Two senior officials have resigned from their positions within the US Food and Drug Administration over frustrations with the Biden administration’s plans to move forward with recommending COVID-19 booster shots without their prior approval, according to a report.

Marion Gruber, director of the FDA’s Office of Vaccines Research & Review, and deputy director Phil Krause are set to leave the agency this fall, with sources telling Politico that the two officials were at odds with the FDA’s top vaccine official, Peter Marks, and were discontented over the roles of the Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices in decisions that they believed should be handled by the FDA.